Is It Safe to Prevent and Treat Postmenopausal Osteoporosis

作者: John C. Stevenson , Thomas E. J. Stevenson

DOI: 10.1007/978-3-319-03494-2_20

关键词:

摘要: Osteoporosis is a major health problem, and various treatment options are available to prevent fractures. The efficacy of most therapies similar, but costs vary enormously adverse effects seen with all treatments. HRT the optimal for prevention postmenopausal osteoporosis in terms efficacy, safety, cost. risks this have been overstated far outweighed by benefits. This should be considered as first-line therapy prevention. Bisphosphonates an effective alternative established osteoporosis. They associated number including atrial fibrillation, osteonecrosis jaw, fragility fractures femoral shaft. Whether other will emerge long term remains seen, their skeletal retention time caution against use younger patients. Denosumab new that has convenient dosing schedule not retained skeleton. It powerful anti-resorptive effect thus carries same jaw shaft bisphosphonates. Other treatments less or either withdrawn (calcitonin) limited (strontium ranelate) because effects.

参考文章(38)
Writing Group for the Women's Health Initiative Investigators, Writing Group for the Women's Health Initiative Investigators, None, Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial JAMA. ,vol. 288, pp. 321- 333 ,(2002) , 10.1001/JAMA.288.3.321
Stuart L Silverman, Claus Christiansen, Harry K Genant, Slobodan Vukicevic, José R Zanchetta, Tobie J de Villiers, Ginger D Constantine, Arkadi A Chines, Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. Journal of Bone and Mineral Research. ,vol. 23, pp. 1923- 1934 ,(2008) , 10.1359/JBMR.080710
Charles H Chesnut III, Stuart Silverman, Kim Andriano, Harry Genant, Alberto Gimona, Steven Harris, Douglas Kiel, Meryl LeBoff, Michael Maricic, Paul Miller, Caje Moniz, Munro Peacock, Peter Richardson, Nelson Watts, David Baylink, PROOF Study Group, A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study The American Journal of Medicine. ,vol. 109, pp. 267- 276 ,(2000) , 10.1016/S0002-9343(00)00490-3
ALIYA A. KHAN, GEORGE K.B. SÁNDOR, EDWARD DORE, ARCHIBALD D. MORRISON, MAZEN ALSAHLI, FAIZAN AMIN, EDMUND PETERS, DAVID A. HANLEY, SULTAN R. CHAUDRY, BRIAN LENTLE, DAVID W. DEMPSTER, FRANCIS H. GLORIEUX, ALAN J. NEVILLE, REENA M. TALWAR, CAMERON M. CLOKIE, MAJD AL MARDINI, TERRI PAUL, SUNDEEP KHOSLA, ROBERT G. JOSSE, SUSAN SUTHERLAND, DAVID K. LAM, ROBERT P. CARMICHAEL, NICK BLANAS, DAVID KENDLER, STEVEN PETAK, LOUIS GEORGES STE-MARIE, JACQUES BROWN, A.WAYNE EVANS, LORENA RIOS, JULIET E. COMPSTON, Bisphosphonate associated osteonecrosis of the jaw The Journal of Rheumatology. ,vol. 36, pp. 478- 490 ,(2009) , 10.3899/JRHEUM.080759
T. C. Hillard, S. J. Whitcroft, M. S. Marsh, M. C. Ellerington, B. Lees, M. I. Whitehead, J. C. Stevenson, Long-term effects of transdermal and oral hormone replacement therapy on postmenopausal bone loss Osteoporosis International. ,vol. 4, pp. 341- 348 ,(1994) , 10.1007/BF01622195
Shelley R. Salpeter, Judith M. E. Walsh, Elizabeth Greyber, Edwin E. Salpeter, Brief report: Coronary heart disease events associated with hormone therapy in younger and older women Journal of General Internal Medicine. ,vol. 21, pp. 363- 366 ,(2006) , 10.1111/J.1525-1497.2006.00389.X
Chris R. Cardwell, Christian C. Abnet, Marie M. Cantwell, Liam J. Murray, Exposure to Oral Bisphosphonates and Risk of Esophageal Cancer JAMA. ,vol. 304, pp. 657- 663 ,(2010) , 10.1001/JAMA.2010.1098
M. C. Ellerington, T. C. Hillard, S. I. J. Whitcroft, M. S. Marsh, B. Lees, L. M. Banks, M. I. Whitehead, J. C. Stevenson, Intranasal salmon calcitonin for the prevention and treatment of postmenopausal osteoporosis. Calcified Tissue International. ,vol. 59, pp. 6- 11 ,(1996) , 10.1007/S002239900076
Janne Komi, Kari S. Lankinen, Michael DeGregorio, Jorma Heikkinen, Seppo Saarikoski, Marjo Tuppurainen, Kaija Halonen, Risto Lammintausta, Kalervo Väänänen, Olavi Ylikorkala, Risto Erkkola, Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women. Journal of Bone and Mineral Metabolism. ,vol. 24, pp. 314- 318 ,(2006) , 10.1007/S00774-006-0689-9